Cargando…

Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis

The long-term effects of bariatric surgery on non-alcoholic steatohepatitis (NASH), focusing on liver injury and hepatocyte apoptosis, are not well-established. We here performed a longitudinal study with paired liver biopsies of nine morbidly obese women (median BMI: 42 [38.7; 45.1] kg/m(2)) with N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneck, Anne-Sophie, Anty, Rodolphe, Patouraux, Stéphanie, Bonnafous, Stéphanie, Rousseau, Déborah, Lebeaupin, Cynthia, Bailly-Maitre, Beatrice, Sans, Arnaud, Tran, Albert, Gugenheim, Jean, Iannelli, Antonio, Gual, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990543/ https://www.ncbi.nlm.nih.gov/pubmed/27594839 http://dx.doi.org/10.3389/fphys.2016.00344

Ejemplares similares

ER stress induces NLRP3 inflammasome activation and hepatocyte death
por: Lebeaupin, C, et al.
Publicado: (2015)

The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis
por: Sans, Arnaud, et al.
Publicado: (2019)

SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis
por: Luci, Carmelo, et al.
Publicado: (2021)

Serum Markers of Hepatocyte Death and Apoptosis Are Non Invasive Biomarkers of Severe Fibrosis in Patients with Alcoholic Liver Disease
por: Lavallard, Vanessa Jeannette, et al.
Publicado: (2011)

Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
por: Bertola, Adeline, et al.
Publicado: (2010)

The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesity
por: Anty, Rodolphe, et al.
Publicado: (2019)

No association between binge eating disorder and severity of non‐alcoholic fatty liver disease in severely obese patients
por: Canivet, Clémence M, et al.
Publicado: (2020)

Identification of Adipose Tissue Dendritic Cells Correlated With Obesity-Associated Insulin-Resistance and Inducing Th17 Responses in Mice and Patients
por: Bertola, Adeline, et al.
Publicado: (2012)

Arterial Calcifications in Patients with Liver Cirrhosis Are Linked to Hepatic Deficiency of Pyrophosphate Production Restored by Liver Transplantation
por: Laurain, Audrey, et al.
Publicado: (2022)

Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
por: Luci, Carmelo, et al.
Publicado: (2020)

MCD diet-induced steatohepatitis generates a diurnal rhythm of associated biomarkers and worsens liver injury in Klf10 deficient mice
por: Leclère, Pierre S., et al.
Publicado: (2020)

Osteopontin deficiency aggravates hepatic injury induced by ischemia–reperfusion in mice
por: Patouraux, S, et al.
Publicado: (2014)

Long-Term Results at 10 Years of Pouch Resizing for Roux-en-Y Gastric Bypass Failure
por: Drai, Céline, et al.
Publicado: (2022)

The Osteopontin Level in Liver, Adipose Tissue and Serum Is Correlated with Fibrosis in Patients with Alcoholic Liver Disease
por: Patouraux, Stéphanie, et al.
Publicado: (2012)

Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity
por: Bertola, Adeline, et al.
Publicado: (2009)

Clinical and Economic Impact of Previous Bariatric Surgery on Liver Transplantation: a Nationwide, Population-Based Retrospective Study
por: Iannelli, Antonio, et al.
Publicado: (2021)

Therapeutic Physical Exercise Programs in the Context of NASH Cirrhosis and Liver Transplantation: A Systematic Review
por: Farrugia, Marwin A., et al.
Publicado: (2023)

Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
por: Nassour, Ibrahim, et al.
Publicado: (2017)

DIABETES REMISSION RATE IN DIFFERENT BMI GRADES FOLLOWING ROUX-EN-Y GASTRIC BYPASS
por: COELHO, Daniel, et al.
Publicado: (2018)

Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem
por: Le Garf, Sébastien, et al.
Publicado: (2021)

Rab4b Is a Small GTPase Involved in the Control of the Glucose Transporter GLUT4 Localization in Adipocyte
por: Kaddai, Vincent, et al.
Publicado: (2009)

Retrograde Intussusception after Roux-en-Y Gastric Bypass
por: Kumar, Akshay, et al.
Publicado: (2020)

De novo hiatal hernia of the gastric tube after sleeve gastrectomy
por: Amor, Imed Ben, et al.
Publicado: (2015)

Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery
por: Chen, Fu, et al.
Publicado: (2021)

The Impact of Previous History of Bariatric Surgery on Outcome of COVID-19. A Nationwide Medico-Administrative French Study
por: Iannelli, Antonio, et al.
Publicado: (2020)

Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score–Matched Analysis
por: Abbassi, Ziad, et al.
Publicado: (2021)

The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance
por: Gill, Ryan M., et al.
Publicado: (2023)

A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass
por: Gerhard, Glenn S., et al.
Publicado: (2013)

The Short-Term Remission of Diabetic Nephropathy After Roux-en-Y Gastric Bypass in Chinese Patients of T2DM with Obesity
por: Zhang, Hongwei, et al.
Publicado: (2015)

Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission
por: Arora, Tulika, et al.
Publicado: (2015)

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery
por: Li, Qing-Run, et al.
Publicado: (2018)

Laparoscopic Roux-en-“W” Gastric Bypass
por: Rovito, Peter E.
Publicado: (2004)

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
por: Zhang, Huai, et al.
Publicado: (2023)

How Sustained is Roux-en-Y Gastric Bypass Long-term Efficacy?: Roux-en-Y Gastric Bypass efficacy
por: Guimarães, Marta, et al.
Publicado: (2021)

Risk of Dumping Syndrome after Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: Early Results of a Multicentre Prospective Study
por: Ramadan, M., et al.
Publicado: (2016)

Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis
por: Hirsova, Petra, et al.
Publicado: (2020)

Hepatic and Peripheral Insulin Sensitivity and Diabetes Remission at 1 Month After Roux-en-Y Gastric Bypass Surgery in Patients Randomized to Omentectomy
por: Dunn, Julia P., et al.
Publicado: (2012)

EXTERNAL VALIDATION OF THE DIAREM SCORE AS REMISSION PREDICTOR OF DIABETES MELLITUS TYPE 2 IN OBESE PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS
por: SAMPAIO-NETO, José, et al.
Publicado: (2015)

Meta-analysis of Long-Term Relapse Rate of Type 2 Diabetes Following Initial Remission After Roux-en-Y Gastric Bypass
por: Yu, Zhiqing, et al.
Publicado: (2021)

Remission and Relapse of Dyslipidemia After Vertical Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass in a Racially and Ethnically Diverse Population
por: Coleman, Karen J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pjodhpgk91cl417ovs1hqh2nin